Local Control and Survival Following Concomitant Chemoradiotherapy in Inoperable Stage I Non-Small-Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 74, Issue 5, 2009, Pages 1371-1375

  Campeau, Marie Pierre ^a   Herschtal, Alan ^a   Wheeler, Greg ^a   Mac Manus, Michael ^a   Wirth, Andrew ^a   Michael, Michael ^a   Hogg, Annette ^a   Drummond, Elizabeth ^a   Ball, David ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Chemoradiation; Early stage; Lung cancer; Medically inoperable; Three dimensional conformal radiation therapy

Indexed keywords

CHEMORADIATION; EARLY-STAGE; LUNG CANCER; MEDICALLY INOPERABLE; THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY;

BIOLOGICAL ORGANS; CELL MEMBRANES; CHEMOTHERAPY; FLUORESCENT SCREENS; INFRARED SPECTROMETERS; PATIENT MONITORING; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY; THREE DIMENSIONAL;

TELEVISION PICTURE TUBES;

CARBOPLATIN; DOCETAXEL; FLUORODEOXYGLUCOSE F 18; PACLITAXEL;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INOPERABLE CANCER; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; SURVIVAL RATE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DOSE FRACTIONATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PACLITAXEL; RADIOTHERAPY, CONFORMAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TAXOIDS;

EID: 67651101085     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.10.067     Document Type: Article

References (19)

1. Rowell N.P., and Williams C.J. Radical radiotherapy for Stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable). Cochrane Database Syst Rev (2001) CD002935
2. Rowell N.P., and O'Rourke N.P. Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database Syst Rev (2004) CD002140
3. Auperin A., Rolland E., Curran W., et al. Concomitant radio-chemotherapy (RT-CT) versus sequential RT-CT in locally advanced non-small cell lung cancer: A meta-analysis using individual patient data from randomised clinical trials. [abstract]. J Thorac Oncol 2 Suppl. 4 (2007) S310
4. Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311 (1995) 899-909
5. Ball D., Bishop J., Smith J., et al. A randomised Phase III study of accelerated or standard fraction radiotherapy with or without concurrent carboplatin in inoperable non-small cell lung cancer: Final report of an Australian multi-centre trial. Radiother Oncol 52 (1999) 129-136
6. Ball D.L., Peters L.J., and Smith J. Reasons for the slow implementations of CHART for patients with non-small cell lung cancer in clinical practice. Radiother Oncol 58 (2001) 89-90
7. Gospodarowicz M.M., Henson D.E., Hutter R.V.P., et al. Lung cancer. In: Brundage D., and Mackillop W. (Eds). Prognostic factors in cancer. 2nd ed (2001), Wiley-Liss, New York 351-369
8. Colinet B., Jacot W., Bertrand D., et al. A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: Description and comparison with the Charlson's index. Br J Cancer 93 (2005) 1098-1105
9. Husband J.E., Schwartz L.H., Spencer J., et al. Evaluation of the response to treatment of solid tumours-a consensus statement of the International Cancer Imaging Society. Br J Cancer 90 (2004) 2256-2260
10. Rolland E., Le Chevalier T., Auperin A., et al. Sequential radio-chemotherapy (RT-CT) versus radiotherapy alone (RT) and concomitant RT-CT versus RT alone in locally advanced non-small cell lung cancer (NSCLC): Two meta-analyses using individual patient data (IPD) from randomised clinical trials (RCTs). [abstract]. J Thorac Oncol 2 Suppl. 4 (2007) S309-S310
11. Lagerwaard F.J., Senan S., van Meerbeeck J.P., and Graveland W.J. Has 3-D conformal radiotherapy (3D CRT) improved the local tumour control for Stage I non-small cell lung cancer?. Radiother Oncol 63 (2002) 151-157
12. Hicks R.J., Kalff V., MacManus M.P., et al. (18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer. J Nucl Med 42 (2001) 1596-1604
13. MacManus M.P., Hicks R.J., Matthews J.P., et al. High rate of detection of unsuspected distant metastases by pet in apparent stage III non-small-cell lung cancer: implications for radical radiation therapy. Int J Radiat Oncol Biol Phys 50 (2001) 287-293
14. Fang L.C., Komaki R., Allen P., et al. Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 108-116
15. Qiao X., Tullgren O., Lax I., et al. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 41 (2003) 1-11
16. Jeremic B., Milicic B., Acimovic L., and Milisavljevic S. Concurrent hyperfractionated radiotherapy and low-dose daily carboplatin and paclitaxel in patients with stage III non-small-cell lung cancer: Long-term results of a phase II study. J Clin Oncol 23 (2005) 1144-1151
17. Ball D. Stereotactic radiotherapy for nonsmall cell lung cancer. Curr Opin Pulm Med 14 (2008) 297-302
18. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a Phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24 (2006) 4833-4839
19. Lagerwaard F.J., Haasbeek C.J., Smit E.F., et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for Stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 70 (2008) 685-692